Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca Plc (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca Plc)

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca Plc (LSE: AZN) Latest News

The Mall in Westminster, leading to Buckingham Palace
Investing Articles

If I had to buy just one FTSE 100 stock in 2024, it would be this

| Ben McPoland

This Fool considered which FTSE 100 (INDEXFTSE:UKX) stock he’d buy next year if given only one choice. Here’s the champ…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

Are these 2 FTSE 100 companies recession-resistant?

| Zaven Boyrazian, CFA

Zaven Boyrazian explores two FTSE 100 giants that could outperform the stock market in the event of a near-term recession…

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Investing Articles

Here’s a FTSE 100 giant I’m eyeing up for December!

| Sumayya Mansoor

This Fool explains why this FTSE 100 pharma giant is on her radar. She plans to snap up shares for…

Read more »

Playful senior couple in aprons dancing and smiling while preparing healthy dinner at home
Investing Articles

Here’s 1 thriving FTSE 100 stock I’d snap up in November

| Zaven Boyrazian, CFA

Stock market volatility has created some exciting opportunities within FTSE 100 stocks. But is this business currently the best bargain?

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Value Shares

UK shares near 52-week lows: 2 I like and 1 I’d avoid

| Edward Sheldon, CFA

Edward Sheldon has been scanning the FTSE 350 index for shares trading near their 52-week lows and has identified a…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

Does the AstraZeneca share price scream value?

| Dr. James Fox

Dr James Fox takes a closer look at the AstraZeneca share price following the company's Q3 results. Is this growth-focused…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

After a rocky October, are AstraZeneca shares now a buy?

| Gordon

AstraZeneca shares fell sharply in October following disappointing results in a clinical trial. Are they now primed for a bounce?

Read more »

Businesswoman calculating finances in an office
Investing Articles

What’s going on with the AstraZeneca share price?

| Mark Tovey

The AstraZeneca share price took a nasty nosedive last week. That came after bad news about a lung cancer drug…

Read more »

Investing Articles

Will litigation news help to move the AstraZeneca share price?

| Kevin Godbold

Can the removal of uncertainty over litigation issues get the AstraZeneca share price moving higher in the coming weeks?

Read more »

Middle-aged Caucasian woman deep in thought while looking out of the window
Investing Articles

Which is the best value stock now: AstraZeneca or GSK?

| Kevin Godbold

There’s value in the pharmaceutical sector, but these two FTSE 100 stocks have quite different characteristics to consider.

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

Down 14%! Should I buy the dip in the AstraZeneca share price?

| Ben McPoland

The AstraZeneca share price has been falling in recent weeks and oil giant Shell has quietly regained the FTSE 100…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Here’s why a 2023 stock market crash won’t stop me buying bargain shares

| Matthew Dumigan

Famous investors predict that a stock market crash could be imminent. But our writer shares why this won't stop them…

Read more »